Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Owen B Wallace

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|December 20, 2003
Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activityOwen B Wallace, Timothy I Richardson, Jeffrey A Dodge
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs)Owen B Wallace, Kenneth S Lauwers, Scott A Jones, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Inhibitors of Abeta production: solid-phase synthesis and SAR of alpha-hydroxycarbonyl derivativesOwen B Wallace, David W Smith, Milind S Deshpande, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Benzothiophene and naphthalene derived constrained SERMsOwen B Wallace, Henry U Bryant, Pamela K Shetler, et al.
Journal of Medicinal Chemistry|February 3, 2006
A selective estrogen receptor modulator for the treatment of hot flushesOwen B Wallace, Kenneth S Lauwers, Jeffrey A Dodge, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2019
A survey of core replacements in indole-based HIV-1 attachment inhibitorsTao Wang, Owen B Wallace, Zhongxing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Hydroxytriamides as potent gamma-secretase inhibitorsC V C Prasad, Owen B Wallace, Jeffrey W Noonan, et al.
Endocrinology|July 9, 2005
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulationAndrew G Geiser, Conrad W Hummel, Michael W Draper, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activityNicholas A Meanwell, Owen B Wallace, Henry Wang, et al.
Journal of Medicinal Chemistry|October 28, 2005
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in ratsConrad W Hummel, Andrew G Geiser, Henry U Bryant, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|December 20, 2003
Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activityOwen B Wallace, Timothy I Richardson, Jeffrey A Dodge
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs)Owen B Wallace, Kenneth S Lauwers, Scott A Jones, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Inhibitors of Abeta production: solid-phase synthesis and SAR of alpha-hydroxycarbonyl derivativesOwen B Wallace, David W Smith, Milind S Deshpande, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Benzothiophene and naphthalene derived constrained SERMsOwen B Wallace, Henry U Bryant, Pamela K Shetler, et al.
Journal of Medicinal Chemistry|February 3, 2006
A selective estrogen receptor modulator for the treatment of hot flushesOwen B Wallace, Kenneth S Lauwers, Jeffrey A Dodge, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2019
A survey of core replacements in indole-based HIV-1 attachment inhibitorsTao Wang, Owen B Wallace, Zhongxing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Hydroxytriamides as potent gamma-secretase inhibitorsC V C Prasad, Owen B Wallace, Jeffrey W Noonan, et al.
Endocrinology|July 9, 2005
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulationAndrew G Geiser, Conrad W Hummel, Michael W Draper, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activityNicholas A Meanwell, Owen B Wallace, Henry Wang, et al.
Journal of Medicinal Chemistry|October 28, 2005
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in ratsConrad W Hummel, Andrew G Geiser, Henry U Bryant, et al.
Pageof 2